Literature DB >> 33503899

Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line.

Gaia Palmini1, Cecilia Romagnoli1, Simone Donati1, Roberto Zonefrati1, Gianna Galli1, Francesca Marini1, Teresa Iantomasi1, Alessandra Aldinucci2, Gigliola Leoncini1, Alessandro Franchi3, Giovanni Beltrami4, Domenico Andrea Campanacci5, Rodolfo Capanna3, Maria Luisa Brandi1,6.   

Abstract

Telangiectatic osteosarcoma (TOS) is an aggressive variant of osteosarcoma (OS) with distinctive radiographic, gross, microscopic features, and prognostic implications. Despite several studies on OS, we are still far from understanding the molecular mechanisms of TOS. In recent years, many studies have demonstrated not only that microRNAs (miRNAs) are involved in OS tumorigenesis, development, and metastasis, but also that the presence in high-grade types of OS of cancer stem cells (CSCs) plays an important role in tumor progression. Despite these findings, nothing has been described previously about the expression of miRNAs and the presence of CSCs in human TOS. Therefore, we have isolated/characterized a putative CSC cell line from human TOS (TOS-CSCs) and evaluated the expression levels of several miRNAs in TOS-CSCs using real-time quantitative assays. We show, for the first time, the existence of CSCs in human TOS, highlighting the in vitro establishment of this unique stabilized cell line and an identification of a preliminary expression of the miRNA profile, characteristic of TOS-CSCs. These findings represent an important step in the study of the biology of one of the most aggressive variants of OS and the role of miRNAs in TOS-CSC behavior.

Entities:  

Keywords:  cancer stem cells; microRNAs; telangiectatic osteosarcoma

Mesh:

Substances:

Year:  2021        PMID: 33503899      PMCID: PMC7866083          DOI: 10.3390/ijms22031163

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  120 in total

1.  MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4.

Authors:  Bingpeng Chen; Jingjing Liu; Ji Qu; Yang Song; Yuxiang Li; Su Pan
Journal:  Tumour Biol       Date:  2017-07

2.  The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer.

Authors:  Toshitaka Sakai; Hirosato Mashima; Yumi Yamada; Takashi Goto; Wataru Sato; Takahiro Dohmen; Kentaro Kamada; Masato Yoshioka; Hiroshi Uchinami; Yuzo Yamamoto; Hirohide Ohnishi
Journal:  Pancreas       Date:  2014-08       Impact factor: 3.327

Review 3.  LIN28: A Stem Cell Factor with a Key Role in Pediatric Tumor Formation.

Authors:  Ilana Carmel-Gross; Naomi Bollag; Leah Armon; Achia Urbach
Journal:  Stem Cells Dev       Date:  2016-02-17       Impact factor: 3.272

Review 4.  Primary bone osteosarcoma in the pediatric age: state of the art.

Authors:  Alessandra Longhi; Costantino Errani; Massimiliano De Paolis; Mario Mercuri; Gaetano Bacci
Journal:  Cancer Treat Rev       Date:  2006-07-24       Impact factor: 12.111

5.  Ultrastructure of telangiectatic osteosarcoma.

Authors:  A Roessner; H P Hobik; M Immenkamp; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1979-10       Impact factor: 4.553

6.  Clinical significance of tumor miR-21, miR-221, miR-143, and miR-106a as biomarkers in patients with osteosarcoma.

Authors:  Hui Zhao; Peng Yan; Jian Wang; Yuqiang Zhang; Mingchao Zhang; Zaijun Wang; Qiang Fu; Weiguo Liang
Journal:  Int J Biol Markers       Date:  2019-05-14       Impact factor: 2.659

7.  Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma.

Authors:  Gaia Palmini; Roberto Zonefrati; Carmelo Mavilia; Alessandra Aldinucci; Ettore Luzi; Francesca Marini; Alessandro Franchi; Rodolfo Capanna; Annalisa Tanini; Maria Luisa Brandi
Journal:  J Vis Exp       Date:  2016-10-14       Impact factor: 1.355

8.  miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2.

Authors:  Chao Lu; Kan Peng; Hao Guo; Xiaoyu Ren; Shouye Hu; Yuanzhen Cai; Yan Han; Le Ma; Peng Xu
Journal:  Oncol Lett       Date:  2018-06-27       Impact factor: 2.967

9.  Regulatory effects of microRNA‑184 on osteosarcoma via the Wnt/β‑catenin signaling pathway.

Authors:  Zhenguang Du; Fusheng Li; Liangliang Wang; Hai Huang; Shaonian Xu
Journal:  Mol Med Rep       Date:  2018-06-18       Impact factor: 2.952

10.  Mature miR-184 and squamous cell carcinoma of the tongue.

Authors:  Thian-Sze Wong; Wai-Kuen Ho; Jimmy Yu-Wai Chan; Raymond Wai-Man Ng; William Ignace Wei
Journal:  ScientificWorldJournal       Date:  2009-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.